Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Validation of a tool predicting important findings on computed tomography among Crohn's disease patients.

Govani SM, Waljee AK, Kocher KE, Swoger JM, Saul M, Higgins PD. Validation of a tool predicting important findings on computed tomography among Crohn's disease patients. United European gastroenterology journal. 2017 Mar 1; 5(2):270-275.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
   Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions



Abstract:

BACKGROUND: Patients with Crohn's disease (CD) are frequently subjected to computed tomography (CT) in the emergency department (ED). This young population is at higher risk of malignancy from radiation exposure. OBJECTIVES: We aimed to validate a decision tool predicting complications (perforation, abscess or other serious finding) on imaging at two sites. METHODS: We conducted a retrospective review of CT outcomes among patients with CD with ED visits at two tertiary care centers. Inclusion criteria were a CT of the abdomen/pelvis with contrast and complete lab data (erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)) within 24 hours of arrival at the University of Michigan (UM) (2012-2013) and the University of Pittsburgh (UPMC) (2009-2012). Sensitivity, negative predictive value (NPV), miss rate and CT avoidance rate were calculated. RESULTS: At UPMC (n? = 210), the tool had a sensitivity of 88.9% and NPV of 98.0%, potentially saving 47.1% from CT with a miss rate of 1.0%. At UM (n? = 248), the tool had a sensitivity of 90.9% and NPV of 96.0%, saving 40.3% from CT with a miss rate of 1.6%. CONCLUSION: A decision tool using CRP and ESR predicting CT outcomes among CD patients performed well in an external validation, allowing providers to forgo CT use with a low miss rate.





Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.